Evidence map›Paper›PMID 28838147›Full record

ArticleThe Journal of infectious diseases2017

Specific Biomarkers Associated With Neurological Complications and Congenital Central Nervous System Abnormalities From Zika Virus-Infected Patients in Brazil.

Yiu-Wing Kam, Juliana Almeida Leite, Fok-Moon Lum, Jeslin J L Tan, Bernett Lee, Carla C Judice, Daniel Augusto de Toledo Teixeira, Robert Andreata-Santos, Marco A Vinolo, Rodrigo Angerami and 13 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 3 pooled it
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 3 syntheses or guidelines pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 4 institutions in 3 countries.

Yiu-Wing KamSingapore Immunology Network, Agency for Science, Technology and Research (A*STAR).
Juliana Almeida LeiteDepartment of Genetics, Evolution and Bioagents, Institute of Biology, University of Campinas (Unicamp), São Paulo.
Fok-Moon LumSingapore Immunology Network, Agency for Science, Technology and Research (A*STAR).
Jeslin J L TanSingapore Immunology Network, Agency for Science, Technology and Research (A*STAR).
Bernett LeeSingapore Immunology Network, Agency for Science, Technology and Research (A*STAR).
Carla C JudiceDepartment of Genetics, Evolution and Bioagents, Institute of Biology, University of Campinas (Unicamp), São Paulo.
Daniel Augusto de Toledo TeixeiraDepartment of Genetics, Evolution and Bioagents, Institute of Biology, University of Campinas (Unicamp), São Paulo.
Robert Andreata-SantosBiomedical Science Institute, Department of Microbiology, University of São Paulo.
Marco A VinoloDepartment of Genetics, Evolution and Bioagents, Institute of Biology, University of Campinas (Unicamp), São Paulo.
Rodrigo AngeramiEpidemiological Surveillance Section, Hospital of Clinics.
Mariangela Ribeiro ResendeDepartment of Internal Medicine, Faculty of Medical Sciences, Unicamp, Campinas, São Paulo.
Andre Ricardo Ribas FreitasObstetrics and Gynecology Department, School of Medical Sciences, University of Campinas (Unicamp).
Eliana AmaralCampinas Department of Public Health Surveillance, Brazil.
Renato Passini JuniorCampinas Department of Public Health Surveillance, Brazil.
Maria Laura CostaCampinas Department of Public Health Surveillance, Brazil.
José Paulo GuidaCampinas Department of Public Health Surveillance, Brazil.
Clarice Weis ArnsDepartment of Genetics, Evolution and Bioagents, Institute of Biology, University of Campinas (Unicamp), São Paulo.
Luis Carlos S FerreiraBiomedical Science Institute, Department of Microbiology, University of São Paulo.
Laurent RéniaSingapore Immunology Network, Agency for Science, Technology and Research (A*STAR).
Jose Luiz Proença-ModenaDepartment of Genetics, Evolution and Bioagents, Institute of Biology, University of Campinas (Unicamp), São Paulo.
Lisa F P NgSingapore Immunology Network, Agency for Science, Technology and Research (A*STAR).
Fabio T M CostaDepartment of Genetics, Evolution and Bioagents, Institute of Biology, University of Campinas (Unicamp), São Paulo.
Zika-Unicamp Network
Universidade Estadual de Campinas (UNICAMP) · BRAgency for Science, Technology and Research · SGInstitute of Biomedical Science · GBSingapore Immunology Network · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Zika virus (ZIKV) infections have been linked to different levels of clinical outcomes, ranging from mild rash and fever to severe neurological complications and congenital malformations. Methods: We investigated the clinical and immunological response, focusing on the immune mediators profile in 95 acute ZIKV-infected adult patients from Campinas, Brazil. These patients included 6 pregnant women who later delivered during the course of this study. Clinical observations were recorded during hospitalization. Levels of 45 immune mediators were quantified using multiplex microbead-based immunoassays. Results: Whereas 11.6% of patients had neurological complications, 88.4% displayed mild disease of rash and fever. Several immune mediators were specifically higher in ZIKV-infected patients, and levels of interleukin 10, interferon gamma-induced protein 10 (IP-10), and hepatocyte growth factor differentiated between patients with or without neurological complications. Interestingly, higher levels of interleukin 22, monocyte chemoattractant protein 1, TNF-α, and IP-10 were observed in ZIKV-infected pregnant women carrying fetuses with fetal growth-associated malformations. Notably, infants with congenital central nervous system deformities had significantly higher levels of interleukin 18 and IP-10 but lower levels of hepatocyte growth factor than those without such abnormalities born to ZIKV-infected mothers. Conclusions: This study identified several key markers for the control of ZIKV pathogenesis. This will allow a better understanding of the molecular mechanisms of ZIKV infection in patients.

Indexed as

AdolescentAdultAgedAged, 80 and overBiomarkersBrazilChildCytokinesFemaleFetal Growth RetardationHumansInfant, NewbornMaleMiddle AgedNervous System MalformationsPregnancyBiomarkersCytokinescongenital CNS deformitiescytokines and biomarkersZika virus

Identifiers

PMID28838147
PMCPMC5853428
OpenAlexW2618918047

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.